Iridex (IRIX) Interest & Investment Income (2010 - 2011)

Iridex's (IRIX) quarterly Interest & Investment Income came in at -$247000.0 in Q4 2011, down 88.55% quarter-over-quarter from -$131000.0 in Q4 2011.

Iridex (IRIX) Interest & Investment Income (2010 - 2011) Analysis & Trends

Iridex's Interest & Investment Income history runs 2 years deep, the most recent figure standing at -$247000.0 for Q4 2011.

On a quarterly basis, Interest & Investment Income changed N/A year-over-year to -$247000.0 in Q4 2011; TTM through Dec 2011 was -$468000.0, a N/A change from a year earlier, with the FY2026 full-year figure at $324000.0, changed N/A from the prior year.
Interest & Investment Income eased to -$247000.0 in Q4 2011 per IRIX's latest filing, from -$131000.0 in the prior quarter.
Across five years, Interest & Investment Income topped out at $63000.0 in Q4 2010 and bottomed at -$247000.0 in Q4 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int & Inv Inc (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn	106.00 Mn
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn	-
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn	-
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn	-
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn	33.50 Mn
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn	-
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn	-
8	Smith & Nephew	26.99 Bn	26.41 Bn	-	-
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn	40.98 Mn
10	Iridex	15.41 Mn	10.81 Mn	4.74 Mn	-

Download Data